Arcus Biosciences, Inc. (RCUS)
21.24
-0.22
(-1.03%)
USD |
NYSE |
Mar 26, 16:00
21.24
0.00 (0.00%)
After-Hours: 20:00
Arcus Biosciences Cash from Investing (Quarterly) : -182.00M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -1.835B |
| Eli Lilly & Co. | -2.802B |
| Merck & Co., Inc. | -11.20B |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Regeneron Pharmaceuticals, Inc. | 220.30M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -120.00M |
| Cash from Financing (Quarterly) | 286.00M |
| Free Cash Flow | -484.00M |
| Free Cash Flow Per Share (Quarterly) | -1.021 |
| Free Cash Flow to Equity (Quarterly) | -208.00M |
| Free Cash Flow to Firm (Quarterly) | -119.00M |
| Free Cash Flow Yield | -21.20% |